Compare CNTB & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTB | ITRG |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.4M | 576.2M |
| IPO Year | 2020 | 2017 |
| Metric | CNTB | ITRG |
|---|---|---|
| Price | $1.30 | $2.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.67 | $5.13 |
| AVG Volume (30 Days) | 1.6M | ★ 2.1M |
| Earning Date | 08-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $64,000.00 | N/A |
| Revenue This Year | N/A | $67.34 |
| Revenue Next Year | N/A | $25.89 |
| P/E Ratio | ★ N/A | $45.07 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.06 | $1.99 |
| 52 Week High | $3.82 | $4.87 |
| Indicator | CNTB | ITRG |
|---|---|---|
| Relative Strength Index (RSI) | 32.54 | 54.08 |
| Support Level | N/A | $2.64 |
| Resistance Level | $2.78 | $2.97 |
| Average True Range (ATR) | 0.26 | 0.11 |
| MACD | -0.11 | -0.02 |
| Stochastic Oscillator | 11.45 | 63.94 |
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.